Testing for Neuroendocrine Immunohistochemical Markers Should Not Be Performed in Poorly Differentiated NSCCs in the Absence of Neuroendocrine Morphologic Features according to the 2015 WHO Classification.
Overview
publication date
- February 1, 2016
published in
Research
keywords
- Lung Neoplasms
- World Health Organization
Identity
Scopus Document Identifier
- 84958982117
Digital Object Identifier (DOI)
- 10.1016/j.jtho.2015.10.018
PubMed ID
- 26811228
Additional Document Info
has global citation frequency
volume
- 11
issue
- 2